Brief: Sprint Bioscience Gets Positive Partial Results In Ongoing Preclinical Study
Nov 14 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* SPRINT BIOSCIENCE AB - RECEIVED POSITIVE PARTIAL RESULTS
IN
ONGOING PRECLINICAL PROOF-OF-CONCEPT STUDY CONDUCTED IN
COMPANY'S NASH PROGRAM
Source text for Eikon: ID:nMFN4QQpHk
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program